Publications
- Indications of ranibizumab in ophthalmology2012 | Faculty of Medicine in Hradec Králové
- Innovations in the Treatment of the Macular Edema in Retinal Venous Occlusions2011 | Faculty of Medicine in Hradec Králové
- Ranibizumab (Lucentis) in the Treatmnet of Age-Related Macular Degeneration +12009 | Faculty of Medicine in Hradec Králové
- The implication of diabetes mellitus for vision +12009 | Faculty of Medicine in Hradec Králové
- Age-related macular degeneration +22008 | Faculty of Medicine in Hradec Králové
- Haemorheotherapy in ophtalmology (our modification of therapeutic procedure and its effect) +12007 | Faculty of Medicine in Hradec Králové
- Incidence of adverse events after loading phase of the brolucizumab therapy of neovascular AMD: Real-life evidence in the Czech Republic2023 | Faculty of Medicine in Hradec Králové, Central Library of Charles University, First Faculty of Medicine, Third Faculty of Medicine
- Biosimilar SB11 versus reference ranibizumab in neovascular age-related macular degeneration: 1-year phase III randomised clinical trial outcomes2023 | Faculty of Medicine in Hradec Králové, Central Library of Charles University, Third Faculty of Medicine
- Diabetic Macular Edema - Diagnostics and Treatment Guidelines2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine
- Retina2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine
Loading network view...